The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Veterinary Pharmaceutical Drug-Global Market Insights and Sales Trends 2025
Synopsis
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
The global Veterinary Pharmaceutical Drug market size is expected to reach US$ 33280 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Pharmaceutical Drug in various end use industries. The expanding demands from the Companion Animals and Livestock Animals, are propelling Veterinary Pharmaceutical Drug market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Pharmaceutical Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Pharmaceutical Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Pharmaceutical Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Pharmaceutical Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Pharmaceutical Drug covered in this report include Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Meiji, etc.
The global Veterinary Pharmaceutical Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Global Veterinary Pharmaceutical Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Pharmaceutical Drug market, Segment by Type:
Oral
Injection
Other
Global Veterinary Pharmaceutical Drug market, by Application
Companion Animals
Livestock Animals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Pharmaceutical Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Veterinary medicine is the branch of medicine that deals with the prevention, diagnosis and treatment of disease, disorder and injury in non-human animals. The scope of veterinary medicine is wide, covering all animal species, both domesticated and wild, with a wide range of conditions which can affect different species.
The global Veterinary Pharmaceutical Drug market size is expected to reach US$ 33280 million by 2029, growing at a CAGR of 5.1% from 2023 to 2029. The market is mainly driven by the significant applications of Veterinary Pharmaceutical Drug in various end use industries. The expanding demands from the Companion Animals and Livestock Animals, are propelling Veterinary Pharmaceutical Drug market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Injection segment is estimated at % CAGR for the next seven-year period.
The animal drugs market is projected to experience significant growth in the foreseeable future. Factors such as increasing pet ownership, growing demand for livestock products, and the prevalence of animal diseases drive market growth. The market is highly competitive, with several pharmaceutical companies involved in the production and distribution of animal drugs. However, challenges such as stringent regulatory requirements, concerns about antibiotic resistance, and limited accessibility in developing regions may hinder market expansion. Nonetheless, the animal drugs market holds promising opportunities, fueled by the need for effective treatments and preventive measures for animal health, and the growing focus on animal welfare and food safety.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Veterinary Pharmaceutical Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Veterinary Pharmaceutical Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Veterinary Pharmaceutical Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Veterinary Pharmaceutical Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Veterinary Pharmaceutical Drug covered in this report include Boehringer Ingelheim, Zoetis, Elanco Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Meiji, etc.
The global Veterinary Pharmaceutical Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Boehringer Ingelheim
Zoetis
Elanco Animal Health
Merck Animal Health
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Meiji
Ouro Fino Saude
Animalcare Group
Parnell
Global Veterinary Pharmaceutical Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Veterinary Pharmaceutical Drug market, Segment by Type:
Oral
Injection
Other
Global Veterinary Pharmaceutical Drug market, by Application
Companion Animals
Livestock Animals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Veterinary Pharmaceutical Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Veterinary Pharmaceutical Drug
1.1 Veterinary Pharmaceutical Drug Market Overview
1.1.1 Veterinary Pharmaceutical Drug Product Scope
1.1.2 Veterinary Pharmaceutical Drug Market Status and Outlook
1.2 Global Veterinary Pharmaceutical Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Veterinary Pharmaceutical Drug Market Size by Region (2018-2029)
1.4 Global Veterinary Pharmaceutical Drug Historic Market Size by Region (2018-2023)
1.5 Global Veterinary Pharmaceutical Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Veterinary Pharmaceutical Drug Market Size (2018-2029)
1.6.1 North America Veterinary Pharmaceutical Drug Market Size (2018-2029)
1.6.2 Europe Veterinary Pharmaceutical Drug Market Size (2018-2029)
1.6.3 Asia-Pacific Veterinary Pharmaceutical Drug Market Size (2018-2029)
1.6.4 Latin America Veterinary Pharmaceutical Drug Market Size (2018-2029)
1.6.5 Middle East & Africa Veterinary Pharmaceutical Drug Market Size (2018-2029)
2 Veterinary Pharmaceutical Drug Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Injection
2.1.3 Other
2.2 Global Veterinary Pharmaceutical Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Type (2018-2023)
2.2.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Veterinary Pharmaceutical Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Veterinary Pharmaceutical Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Veterinary Pharmaceutical Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Veterinary Pharmaceutical Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Veterinary Pharmaceutical Drug Revenue Breakdown by Type (2018-2029)
3 Veterinary Pharmaceutical Drug Market Overview by Application
3.1 Introduction
3.1.1 Companion Animals
3.1.2 Livestock Animals
3.2 Global Veterinary Pharmaceutical Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Veterinary Pharmaceutical Drug Historic Market Size by Application (2018-2023)
3.2.2 Global Veterinary Pharmaceutical Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Veterinary Pharmaceutical Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Veterinary Pharmaceutical Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Veterinary Pharmaceutical Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Veterinary Pharmaceutical Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Veterinary Pharmaceutical Drug Revenue Breakdown by Application (2018-2029)
4 Veterinary Pharmaceutical Drug Competition Analysis by Players
4.1 Global Veterinary Pharmaceutical Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Pharmaceutical Drug as of 2022)
4.3 Date of Key Players Enter into Veterinary Pharmaceutical Drug Market
4.4 Global Top Players Veterinary Pharmaceutical Drug Headquarters and Area Served
4.5 Key Players Veterinary Pharmaceutical Drug Product Solution and Service
4.6 Competitive Status
4.6.1 Veterinary Pharmaceutical Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Profile
5.1.2 Boehringer Ingelheim Main Business
5.1.3 Boehringer Ingelheim Veterinary Pharmaceutical Drug Products, Services and Solutions
5.1.4 Boehringer Ingelheim Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Boehringer Ingelheim Recent Developments
5.2 Zoetis
5.2.1 Zoetis Profile
5.2.2 Zoetis Main Business
5.2.3 Zoetis Veterinary Pharmaceutical Drug Products, Services and Solutions
5.2.4 Zoetis Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.2.5 Zoetis Recent Developments
5.3 Elanco Animal Health
5.3.1 Elanco Animal Health Profile
5.3.2 Elanco Animal Health Main Business
5.3.3 Elanco Animal Health Veterinary Pharmaceutical Drug Products, Services and Solutions
5.3.4 Elanco Animal Health Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Merck Animal Health Recent Developments
5.4 Merck Animal Health
5.4.1 Merck Animal Health Profile
5.4.2 Merck Animal Health Main Business
5.4.3 Merck Animal Health Veterinary Pharmaceutical Drug Products, Services and Solutions
5.4.4 Merck Animal Health Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Merck Animal Health Recent Developments
5.5 Virbac
5.5.1 Virbac Profile
5.5.2 Virbac Main Business
5.5.3 Virbac Veterinary Pharmaceutical Drug Products, Services and Solutions
5.5.4 Virbac Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Virbac Recent Developments
5.6 Dechra Veterinary Products
5.6.1 Dechra Veterinary Products Profile
5.6.2 Dechra Veterinary Products Main Business
5.6.3 Dechra Veterinary Products Veterinary Pharmaceutical Drug Products, Services and Solutions
5.6.4 Dechra Veterinary Products Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Dechra Veterinary Products Recent Developments
5.7 Ceva
5.7.1 Ceva Profile
5.7.2 Ceva Main Business
5.7.3 Ceva Veterinary Pharmaceutical Drug Products, Services and Solutions
5.7.4 Ceva Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.7.5 Ceva Recent Developments
5.8 Vetoquinol
5.8.1 Vetoquinol Profile
5.8.2 Vetoquinol Main Business
5.8.3 Vetoquinol Veterinary Pharmaceutical Drug Products, Services and Solutions
5.8.4 Vetoquinol Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Vetoquinol Recent Developments
5.9 Meiji
5.9.1 Meiji Profile
5.9.2 Meiji Main Business
5.9.3 Meiji Veterinary Pharmaceutical Drug Products, Services and Solutions
5.9.4 Meiji Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Meiji Recent Developments
5.10 Ouro Fino Saude
5.10.1 Ouro Fino Saude Profile
5.10.2 Ouro Fino Saude Main Business
5.10.3 Ouro Fino Saude Veterinary Pharmaceutical Drug Products, Services and Solutions
5.10.4 Ouro Fino Saude Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Ouro Fino Saude Recent Developments
5.11 Animalcare Group
5.11.1 Animalcare Group Profile
5.11.2 Animalcare Group Main Business
5.11.3 Animalcare Group Veterinary Pharmaceutical Drug Products, Services and Solutions
5.11.4 Animalcare Group Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Animalcare Group Recent Developments
5.12 Parnell
5.12.1 Parnell Profile
5.12.2 Parnell Main Business
5.12.3 Parnell Veterinary Pharmaceutical Drug Products, Services and Solutions
5.12.4 Parnell Veterinary Pharmaceutical Drug Revenue (US$ Million) & (2018-2023)
5.12.5 Parnell Recent Developments
6 North America
6.1 North America Veterinary Pharmaceutical Drug Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Veterinary Pharmaceutical Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Pharmaceutical Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Veterinary Pharmaceutical Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Pharmaceutical Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Veterinary Pharmaceutical Drug Market Dynamics
11.1 Veterinary Pharmaceutical Drug Industry Trends
11.2 Veterinary Pharmaceutical Drug Market Drivers
11.3 Veterinary Pharmaceutical Drug Market Challenges
11.4 Veterinary Pharmaceutical Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
